share_log

康弘药业:2023年度独立董事述职报告(邓宏光)

Kanghong Pharmaceutical: 2023 Independent Director Debriefing Report (Deng Hongguang)

SZSI ·  Apr 25

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.